Jci_page_head_homepage_01 Jci_page_head_homepage_02
Stephan Grabbe, Georg Varga, Stefan Beissert, Meike Steinert, Gunther Pendl, Stephan Seeliger, Wilhelm Bloch, Thorsten Peters, Thomas Schwarz, Cord Sunderkötter, Karin Scharffetter-Kochanek
Published in Volume 109, Issue 2
J Clin Invest. 2002; 109(2):183–192 doi:10.1172/JCI11703
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 6

Hapten-specific activation of regional LN cells. Regional LNs were obtained from DNFB-sensitized mice 3 days after sensitization. (a) Fold increase in LN cells after sensitization with either vehicle only (0% DNFB), 0.1%, or 0.5% DNFB. (b) Hapten-specific proliferation of LN cells in response to either the specific hapten, DNBS, or a control hapten, FITC. Thy-1.2+ T cells were generated from LN cells and cultured together with hapten-coupled DCs for 72 hours, and then pulsed with 3H for an additional 18 hours. Due to the different proliferative capacities of CD18–/– and CD18+/+ T cells, a proliferation index was calculated as cpm after stimulation with hapten-exposed DCs, divided by cpm after stimulation with untreated DCs. A proliferation index greater than 1 indicates hapten-specific T cell proliferation. Inset: Allogeneic mixed lymphocyte reaction with purified T cells from CD18–/– or CD18+/+ mice as responders, and various numbers of allogeneic DCs (156–20,000) as stimulators. (c) Hapten-specific T cell activation as measured by upregulation of the activation marker CD69. Numbers in boxes indicate the percentage of CD69-expressing cells among the CD4+ and CD8+ T cells.